Related Experiment Video
Updated: Jan 22, 2026

An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Short-Course Tuberculosis Preventive Therapy in a High Migration Setting: Early Experience With 1HP in Cook County,
Samuel Starke1,2, Keziah Thomas3, Supriya Jasuja3
1Division of Infectious Diseases, Rush University Medical Center, Chicago, Illinois, USA.
None:
In a U.S. health department TB program serving primarily non-U.S.-born clients, 78% of those evaluated for latent TB infection initiated TB preventive therapy, with 71% completing treatment. Completion was lower among newly arrived migrants. A novel one-month isoniazid-rifapentine regimen (1HP) was well tolerated, with similar completion rates to conventional regimens.
Related Concept Videos
Urinary Tract Calculi IV: Nutrition Therapy and Prevention
Cancer Prevention
Some...
Gene Therapy
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

